IBEC Seminar: Dr. Silvia Muro, Nanobiotechnology for drug delivery
Nanobiotechnology for drug delivery: fundamental aspects and translational applications
Nanobiotechnology for drug delivery: fundamental aspects and translational applications
Nanobio-technology for drug delivery: fundamental aspects and translational applications Dr. Silvia Muro, University of Maryland, College Park, MD, USA The design of targeting and carrier strategies to enable delivery of … Read more
Nanobio-technology for drug delivery: fundamental aspects and translational applications Dr. Silvia Muro, University of Maryland, College Park, MD, USA The design of targeting and carrier strategies to enable delivery of … Read more
This week a new PhD programme at IBEC funded by the Obra Social “La Caixa”, INPhINIT, opens for applications.INPhINIT aims to attract international early-stage researchers to the top Spanish research centres in the areas of the life and health sciences, physics, technology, engineering and maths.
In each call, INPhINIT recruits 57 candidates of any nationality, who enjoy a three-year employment contract at the participating research centre of their choice, all of which have been designated by the Spanish ministries as Severo Ochoa, Maria de Maeztu or Carlos III Centres or Units of Excellence.
Programa Indústria del Coneixement LLAVOR 2014 Projecte summary: The medical community has a growing interest in the correct acquisition of surgical abilities by new surgeons and residents and proposes training … Read more
Application Deadline: 02/02/2017
INPhINIT is a new doctoral fellowship programme devoted to attracting international Early-Stage Researchers to the top Spanish research centres in the areas of Bio and Health Sciences, Physics, Technology, Engineering and Mathematics. INPhINIT recruits per call 57 Early-Stage Researchers of any nationality, who enjoy a 3-year employment contract at the Research Centre of their choice among those selected and awarded by the Spanish Ministry of Economy and Competitiveness (“Severo Ochoa” centres of excellence and “Maria de Maeztu” units of excellence) and the Spanish Ministry of Health (“Carlos III centres of excellence”).
Last week saw the launch of the ADVANCECAT project, led by the University of Barcelona. Part of the RIS3CAT community, ADVANCECAT aims to accelerate the development of advanced therapies – medicines based on cell therapy, gene therapy and tissue engineering – in Catalonia from basic research to clinical or industrial transfer.
Formed by 18 organizations in the field of health including two universities, twelve biomedical research institutes – including IBEC – and four companies and private foundations, ADVANCECAT, which is integrated in the NextHealth community and coordinated by Biocat, will bring together public and private sectors for better management of resources in order to get the most out of the Catalan health system.
“Finite element simulation of the healthy and degenerated lumbar spine. Interplay between muscle activity and intervertebral disc multiphysics.”
“Finite element simulation of the healthy and degenerated lumbar spine. Interplay between muscle activity and intervertebral disc multiphysics.”
“Finite element simulation of the healthy and degenerated lumbar spine. Interplay between muscle activity and intervertebral disc multiphysics.”